Intranasal CpG Therapy Attenuated Experimental Fungal Asthma in a TLR9-dependent and -independent Manner

Overview

Journal Int Arch Allergy Immunol

Specialty Allergy & Immunology

Date 2009 Dec 18

PMID 20016192

Citations 11

Authors

Hemanth Ramaprakash

Cory M Hogaboam

Affiliations

Soon will be listed here.

Abstract

Background: CpG administration abolishes airway inflammation and remodeling in acute models of allergic airway disease.

Methods: Herein, we investigated the therapeutic effect of CpG in a chronic fungal model of asthma. TLR9+/+ and TLR9-/- mice were sensitized to soluble Aspergillus fumigatus antigens and challenged with live A. fumigatus conidia. Mice were treated with intraperitoneal (IP) or intranasal (IN) CpG, or left untreated 14-28 days after conidium challenge. All features of allergic airway disease were attenuated in TLR9+/+ mice treated with IN CpG, including airway hyperresponsiveness (AHR), mucus production, and peribronchial fibrosis.

Results: TLR9-/- mice treated with IN CpG exhibited attenuated airway remodeling but not AHR. Whole-lung IL-12 levels were significantly elevated in both TLR9+/+ and TLR9-/- mice receiving IN CpG but not in either group receiving IP CpG. Whole-lung IL-10 levels were significantly elevated in IN CpG-treated TLR9+/+ mice but not in TLR9-/- mice receiving IN CpG. Increased whole-lung transcript and protein levels of the scavenger receptors SR-A and MARCO were observed in TLR9-/- mice compared with TLR9+/+ mice, possibly accounting for the CpG responsiveness in the knockout group.

Conclusions: Together, these data show that IN CpG has a therapeutic effect during established fungal asthma, which is TLR9 dependent and independent.

Citing Articles

Animal Models of Aspergillosis.

Desoubeaux G, Cray C Comp Med. 2018; 68(2):109-123.

PMID: 29663936 PMC: 5897967.

Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.

Wirsdorfer F, Jendrossek V Radiat Oncol. 2017; 12(1):142.

PMID: 28836991 PMC: 5571607. DOI: 10.1186/s13014-017-0865-1.

CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans.

Van Prooyen N, Henderson C, Hocking Murray D, Sil A PLoS Pathog. 2016; 12(7):e1005749.

PMID: 27459510 PMC: 4961300. DOI: 10.1371/journal.ppat.1005749.

Immune responses to airborne fungi and non-invasive airway diseases.

Vacher G, Niculita-Hirzel H, Roger T Semin Immunopathol. 2014; 37(2):83-96.

PMID: 25502371 DOI: 10.1007/s00281-014-0471-3.

Lymphocyte-based model systems for allergy research: a historic overview.

Neunkirchner A, Schmetterer K, Pickl W Int Arch Allergy Immunol. 2014; 163(4):259-91.

PMID: 24777172 PMC: 7617143. DOI: 10.1159/000360163.

References

Arredouani M, Franco F, Imrich A, Fedulov A, Lu X, Perkins D . Scavenger Receptors SR-AI/II and MARCO limit pulmonary dendritic cell migration and allergic airway inflammation. J Immunol. 2007; 178(9):5912-20. DOI: 10.4049/jimmunol.178.9.5912. View

Jeffery P . Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005; 1(3):176-83. DOI: 10.1513/pats.200402-009MS. View

Krieg A . Antiinfective applications of toll-like receptor 9 agonists. Proc Am Thorac Soc. 2007; 4(3):289-94. PMC: 2647632. DOI: 10.1513/pats.200701-021AW. View

Racila D, Kline J . Perspectives in asthma: molecular use of microbial products in asthma prevention and treatment. J Allergy Clin Immunol. 2005; 116(6):1202-5. DOI: 10.1016/j.jaci.2005.08.050. View

Cho J, Miller M, Baek K, Han J, Nayar J, Rodriguez M . Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. Am J Respir Cell Mol Biol. 2003; 30(5):651-61. DOI: 10.1165/rcmb.2003-0066OC. View

Krieg A . Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006; 5(6):471-84. DOI: 10.1038/nrd2059. View

Phipps S, Lam C, Foster P, Matthaei K . The contribution of toll-like receptors to the pathogenesis of asthma. Immunol Cell Biol. 2007; 85(6):463-70. DOI: 10.1038/sj.icb.7100104. View

Nolles G, Hoekstra M, Schouten J, Gerritsen J, Kauffman H . Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy. 2001; 31(10):1564-70. DOI: 10.1046/j.1365-2222.2001.01186.x. View

Hirose I, Tanaka H, Takahashi G, Wakahara K, Tamari M, Sakamoto T . Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice. Int Arch Allergy Immunol. 2008; 147(1):6-16. DOI: 10.1159/000128581. View

10.

McCluskie M, Davis H . CpG DNA as mucosal adjuvant. Vaccine. 1999; 18(3-4):231-7. DOI: 10.1016/s0264-410x(99)00194-2. View

11.

Vissers J, Van Esch B, Jeurink P, Hofman G, van Oosterhout A . Stimulation of allergen-loaded macrophages by TLR9-ligand potentiates IL-10-mediated suppression of allergic airway inflammation in mice. Respir Res. 2004; 5:21. PMC: 534803. DOI: 10.1186/1465-9921-5-21. View

12.

Ying S, OConnor B, Ratoff J, Meng Q, Fang C, Cousins D . Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008; 181(4):2790-8. DOI: 10.4049/jimmunol.181.4.2790. View

13.

Broide D, Stachnick G, Castaneda D, Nayar J, Miller M, Cho J . Systemic administration of immunostimulatory DNA sequences mediates reversible inhibition of Th2 responses in a mouse model of asthma. J Clin Immunol. 2001; 21(3):175-82. DOI: 10.1023/a:1011078930363. View

14.

Kline J . Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc. 2007; 4(3):283-8. PMC: 2647631. DOI: 10.1513/pats.200701-019AW. View

15.

Jozefowski S, Sulahian T, Arredouani M, Kobzik L . Role of scavenger receptor MARCO in macrophage responses to CpG oligodeoxynucleotides. J Leukoc Biol. 2006; 80(4):870-9. DOI: 10.1189/jlb.0705357. View

16.

Kline J, Krieg A, Waldschmidt T, Ballas Z, Jain V, Businga T . CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol. 1999; 104(6):1258-64. DOI: 10.1016/s0091-6749(99)70022-9. View

17.

Ramaprakash H, Ito T, Standiford T, Kunkel S, Hogaboam C . Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice. Infect Immun. 2008; 77(1):108-19. PMC: 2612288. DOI: 10.1128/IAI.00998-08. View

18.

Hogaboam C, Blease K, Mehrad B, Steinhauser M, Standiford T, Kunkel S . Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol. 2000; 156(2):723-32. PMC: 1850050. DOI: 10.1016/S0002-9440(10)64775-X. View

19.

Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

20.

Kitagaki K, Jain V, Businga T, Hussain I, Kline J . Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses. Clin Diagn Lab Immunol. 2002; 9(6):1260-9. PMC: 130087. DOI: 10.1128/cdli.9.6.1260-1269.2002. View